This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Evolution of the Science of Treating Hypertension

Timothy C. Fagan, MD

Arch Intern Med. 1997;157(21):2401-2402.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE SIXTH Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" (JNC VI)¹ documents major progress in the scientific basis for treatment of hypertension and recognizes advances in the availability of major new classes of drugs that have clear benefits in treating hypertension under certain conditions. This report also documents some major failings. The number of individuals with high blood pressure who were identified, treated, and had their disease controlled increased steadily from 1976 through 1991.¹ This was paralleled by dramatic decreases in death from stroke and coronary heart disease.¹ However, from 1991 to 1994 the rates of detection, treatment, and control did not improve and the declines in stroke and coronary heart disease appear to have plateaued.¹

The fourth JNC report (JNCIV), published in 1988,² listed 5 broad classes of antihypertensive drugs, composed of 47 individual agents. . . . [Full Text PDF of this Article]

Author Affiliations
5620 N Kolb Rd, Suite 166 Tucson, AZ 85750

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?